Researchers in the United States and India have conducted a study demonstrating the real-world effectiveness of a single dose of Johnson & Johnson’s Ad26.COV2.S vaccine at preventing infection with severe acute respiratory syndrome coronavirus 2 – the agent that causes coronavirus disease 2019 (COVID-19).
The team compared the SARS-CoV-2 infection rate among more than 1,700 individuals who received one vaccine shot with the rate among more than 17,700 unvaccinated, propensity-matched controls.
- Health18 hours ago
New STRENGTH analysis puts spotlight on CV impact of omega-3 fatty acids – Healio
- Local News9 hours ago
BREAKING: SHARK ATTACK AT TUNCURRY A man has been bitten by a shark at Tuncurry…
- Science22 hours ago
Chinese observatory detects cosmic light that may rewrite laws of physics – South China Morning Post
- Science18 hours ago
What Is a Blood Moon? – Space.com